{
  "ticker": "SIGA",
  "company_name": "SIGA Technologies Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT00728689",
      "title": "Phase I Trial of an Investigational Small Pox Medication",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Orthopoxviral Disease, Smallpox, Monkey Pox",
      "start_date": "2008-08",
      "completion_date": "2008-10",
      "enrollment": 0,
      "sponsor": "SIGA Technologies"
    },
    {
      "nct_id": "NCT04971109",
      "title": "Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Smallpox",
      "start_date": "2022-03-29",
      "completion_date": "2023-05-12",
      "enrollment": 0,
      "sponsor": "SIGA Technologies"
    },
    {
      "nct_id": "NCT02474589",
      "title": "A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Smallpox",
      "start_date": "2015-06-19",
      "completion_date": "2016-08-24",
      "enrollment": 0,
      "sponsor": "SIGA Technologies"
    },
    {
      "nct_id": "NCT00431951",
      "title": "Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2007-02",
      "completion_date": "2008-02",
      "enrollment": 0,
      "sponsor": "SIGA Technologies"
    },
    {
      "nct_id": "NCT05534984",
      "title": "Study of Tecovirimat for Human Mpox Virus",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE3",
      "condition": "MPOX",
      "start_date": "2022-09-12",
      "completion_date": "2025-09-30",
      "enrollment": 0,
      "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)"
    },
    {
      "nct_id": "NCT03972111",
      "title": "A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox",
      "status": "WITHDRAWN",
      "phase": "",
      "condition": "Smallpox",
      "start_date": "2020-01-01",
      "completion_date": "2024-09-30",
      "enrollment": 0,
      "sponsor": "SIGA Technologies"
    },
    {
      "nct_id": "NCT04957485",
      "title": "Study to Assess the Safety and Immunogenicity of TPOXX\u00ae When Administered Orally for 28 Days With JYNNEOS",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Smallpox",
      "start_date": "2022-04-05",
      "completion_date": "2026-01-01",
      "enrollment": 0,
      "sponsor": "SIGA Technologies"
    },
    {
      "nct_id": "NCT05380752",
      "title": "Tecovirimat Intravenous Treatment for Orthopox Virus Exposure",
      "status": "NO_LONGER_AVAILABLE",
      "phase": "",
      "condition": "Orthopox Virus Infection",
      "start_date": "",
      "completion_date": "",
      "enrollment": 0,
      "sponsor": "U.S. Army Medical Research and Development Command"
    },
    {
      "nct_id": "NCT00907803",
      "title": "Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Orthopoxviral Disease",
      "start_date": "2009-06",
      "completion_date": "2010-01",
      "enrollment": 0,
      "sponsor": "SIGA Technologies"
    },
    {
      "nct_id": "NCT04392739",
      "title": "Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG",
      "status": "COMPLETED",
      "phase": "PHASE4",
      "condition": "Smallpox",
      "start_date": "2019-07-19",
      "completion_date": "2019-12-05",
      "enrollment": 0,
      "sponsor": "SIGA Technologies"
    }
  ],
  "summary": {
    "total_trials": 11,
    "by_phase": {
      "PHASE1": 2,
      "PHASE3": 3,
      "": 2,
      "PHASE2": 2,
      "PHASE4": 2
    },
    "by_status": {
      "COMPLETED": 7,
      "ACTIVE_NOT_RECRUITING": 2,
      "WITHDRAWN": 1,
      "NO_LONGER_AVAILABLE": 1
    },
    "active_trials": 2,
    "completed_trials": 7,
    "conditions": [
      "Healthy",
      "MPOX",
      "Orthopox Virus Infection",
      "Orthopoxviral Disease",
      "Orthopoxviral Disease, Smallpox, Monkey Pox",
      "Smallpox"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:51.313678",
    "search_query": "SIGA Technologies Inc.",
    "url": "https://clinicaltrials.gov/search?term=SIGA+Technologies+Inc."
  }
}